薬用菓子類市場：タイプ、ラベリング、流通チャネル別-2025-2030年の世界予測

薬用菓子類市場は、2023年に62億8,000万米ドルと評価され、2024年には66億4,000万米ドルに達すると予測され、CAGR 6.07％で成長し、2030年には95億米ドルに達すると予測されています。

薬用菓子類には、お菓子の魅力と治療効果を組み合わせた製品が含まれ、喉の炎症を和らげたり、咳を緩和したり、栄養補助食品として使用されることが多いです。このカテゴリーには、メントール、ビタミン、植物成分などの医療成分を配合したトローチ、ガム、キャンディが含まれます。薬用菓子類の必要性は、押し付けがましくなく、嗜好性の高い形態の医薬品を求める消費者の需要に由来します。その用途は、風邪やインフルエンザの治療、のどの痛みの緩和、口腔ケア、栄養強化など多岐にわたる。最終用途の範囲は、薬局で広く入手可能なヘルスケア分野と、食料品店やコンビニエンスストアを通じた直接消費者市場の両方を対象としています。主な成長要因としては、消費者の健康意識の高まり、高齢者人口の増加、市販薬を好むライフスタイルの変化などが挙げられます。糖尿病患者向けの砂糖不使用の選択肢や、COVID-19パンデミックの余波を受けた免疫力強化製品など、特定の層向けに製品を調整することに潜在的なビジネスチャンスがあります。企業は、オーガニックや非遺伝子組み換えの製剤で製品ポートフォリオを拡大し、健康志向の動向を取り込むことを検討すべきです。課題としては、健康強調表示や成分の使用に関する厳しい規制、伝統的な医薬品や機能性食品との競合が挙げられます。さらに、効能効果に対する消費者の懐疑心が市場成長の妨げになる可能性もあります。イノベーションは、成分の透明性と、有効性の向上と味のマスキングを目的としたナノカプセル化などの最先端の送達システムの活用に重点を置くべきです。市場はダイナミックであり、技術の進歩や消費者の動向によって競合情勢が左右されるため、企業は継続的に戦略を適応させて関連性を維持する必要があります。成長機会を活用するために、企業は健康専門家とのコラボレーションを促進し、製品の主張を検証してブランドの信頼性を高めるとともに、消費者教育に投資して薬用菓子類の利点と用途を解明する必要があります。

市場力学：急速に進化する薬用菓子類市場の主要市場インサイトを公開

薬用菓子類市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 強化/機能性菓子類への需要の高まり
  • 菓子類における有効成分の需要増加
  • アレルギーと花粉症の増加
• 市場抑制要因
  • 薬用菓子類の誤解による限定的な普及率
• 市場機会
  • フレーバーと健康成分の革新
  • 研究開発への投資増加
• 市場の課題
  • 薬用菓子類原材料価格の変動

ポーターの5つの力：薬用菓子類市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、薬用菓子類市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：薬用菓子類市場における外部からの影響の把握

外部マクロ環境要因は、薬用菓子類市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析薬用菓子類市場における競合情勢の把握

薬用菓子類市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス薬用菓子類市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、薬用菓子類市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 強化・機能菓子類製品の需要増加
    • 菓子類の有効成分の需要増加
    • アレルギーや花粉症の増加
  • 抑制要因
    • 薬用菓子に対する誤解により普及率が低迷
  • 機会
    • フレーバーと健康成分のイノベーション
    • 研究開発活動への投資の増加
  • 課題
    • 薬用菓子類原材料価格の変動
• 市場セグメンテーション分析
  • タイプ：喉の痛みに効き目があり、持続性のあるハードボイルドキャンディーの需要が高まっています
  • ラベル：健康意識と食事制限の高まりにより、無糖食品の人気が高まっています。
  • 流通チャネル：アクセスの容易さと利便性によりオンラインチャネルの利用が増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境
• 顧客のカスタマイズ

第6章 薬用菓子類市場：タイプ別

• チューインガム
• ハードボイルドキャンディー
• トローチ

第7章 薬用菓子類市場ラベル付け

• 従来型
• 砂糖不使用

第8章 薬用菓子類市場：流通チャネル別

• コンビニエンスストア
• オンライン小売
• 専門店
• スーパーマーケットとハイパーマーケット

第9章 南北アメリカの薬用菓子類市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の薬用菓子類市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの薬用菓子類市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • エイパックス・ファンドがバズーカ・キャンディ・ブランドを買収
  • ネスレは菓子類を含む栄養強化製品に数十億米ドルの投資を約束

企業一覧

• A.L.Simpkin & Co. Ltd.
• Enorama Pharma AB
• Tereos S.A.
• Mondelez International, Inc.
• Reckitt Benckiser Group PLC
• Baker Perkins Limited by Schenck Process Group
• Nestle S.A. BY Ferrero International S.A.
• Prince Group
• Lofthouse of Fleetwood Ltd.
• Skyepharma Production S.A.S.
• Syntegon Technology GmbH
• Lozy's pharmaceuticals, S.L.
• Ernest Jackson Ltd.
• GelStat Corporation
• Hamac Food Industries Sdn Bhd
• Piedmont Candy Company
• Swan Sweets Pvt. Ltd
• Herbion International Inc. by Kehkashan Group
• Perfetti Van Melle Group B.V.
• Cargill, Inc.
• Glanbia PLC
• UHA Mikakuto Co.Ltd.
• Bartek Ingredients Inc.
• Mars Incorporated
• Creasy Foods Ltd.
• Lozen Pharma Pvt. Ltd.

LIST OF FIGURES

• FIGURE 1. MEDICATED CONFECTIONERY MARKET RESEARCH PROCESS
• FIGURE 2. MEDICATED CONFECTIONERY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS MEDICATED CONFECTIONERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS MEDICATED CONFECTIONERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES MEDICATED CONFECTIONERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES MEDICATED CONFECTIONERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC MEDICATED CONFECTIONERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC MEDICATED CONFECTIONERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MEDICATED CONFECTIONERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MEDICATED CONFECTIONERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. MEDICATED CONFECTIONERY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. MEDICATED CONFECTIONERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MEDICATED CONFECTIONERY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MEDICATED CONFECTIONERY MARKET DYNAMICS
• TABLE 7. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY CHEWING GUMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY HARD BOILED CANDIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY PASTILLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY SUGAR-FREE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY CONVENIENCE STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY SPECIALIST STORES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL MEDICATED CONFECTIONERY MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS MEDICATED CONFECTIONERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 29. CANADA MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 31. CANADA MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES MEDICATED CONFECTIONERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC MEDICATED CONFECTIONERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. CHINA MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 48. CHINA MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 49. INDIA MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 51. INDIA MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA MEDICATED CONFECTIONERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 101. ITALY MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 103. ITALY MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 113. POLAND MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 115. POLAND MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 116. QATAR MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 118. QATAR MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM MEDICATED CONFECTIONERY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM MEDICATED CONFECTIONERY MARKET SIZE, BY LABELING, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM MEDICATED CONFECTIONERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 146. MEDICATED CONFECTIONERY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. MEDICATED CONFECTIONERY MARKET, FPNV POSITIONING MATRIX, 2023

The Medicated Confectionery Market was valued at USD 6.28 billion in 2023, expected to reach USD 6.64 billion in 2024, and is projected to grow at a CAGR of 6.07%, to USD 9.50 billion by 2030.

Medicated confectionery encompasses products that combine the appeal of sweets with therapeutic benefits, often used to soothe throat irritations, alleviate cough, or provide nutritional supplements. This category includes lozenges, gums, and candies enriched with medical ingredients such as menthol, vitamins, or botanicals. The necessity of medicated confectionery originates from consumer demand for non-intrusive, palatable forms of medicine, often preferred for their ease of administration, especially among children and the elderly. The application ranges across therapeutic solutions for colds and flu, sore throat relief, oral care, and nutritional enhancement. The end-use scope targets both healthcare sectors, making it widely available in pharmacies, and direct consumer markets via grocery and convenience stores. Key growth influences include increasing consumer health awareness, a rising geriatric population, and lifestyle shifts favoring over-the-counter remedies. Potential opportunities lie in tailoring products for specific demographics, such as sugar-free options for diabetics or products enhancing immunity, given the aftermath of the COVID-19 pandemic. Companies should explore expanding their product portfolios with organic and non-GMO formulations, tapping into health-conscious trends. Challenges involve stringent regulations regarding health claims and ingredient usage and competition from traditional medicinal forms and functional foods. Furthermore, consumer skepticism about efficacy can hinder market growth. Innovation should focus on ingredient transparency and leveraging cutting-edge delivery systems like nanoencapsulation for enhanced efficacy and taste masking. The market is dynamic, with a competitive landscape driven by technological advancements and consumer trends, emphasizing the necessity for companies to continuously adapt strategies to maintain relevance. To capitalize on growth opportunities, businesses should foster collaboration with health experts to validate product claims and enhance brand credibility, while investing in consumer education to demystify the benefits and applications of medicated confectionery.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Medicated Confectionery Market

The Medicated Confectionery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing Demand for Fortified/Functional Confectionery Products
  • Rising Demand for Active Ingredients in Confectionery
  • Increasing Cases of Allergy and Hay Fevers
• Market Restraints
  • Limited Adoption Rate Due to Misconception of Medicated Confectioneries
• Market Opportunities
  • Innovations in Flavor and Health Ingredients
  • Rising Investments in the Research and Development Activities
• Market Challenges
  • Volatility in Raw Material Prices of Medicated Confectionery Ingredients

Porter's Five Forces: A Strategic Tool for Navigating the Medicated Confectionery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Medicated Confectionery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Medicated Confectionery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Medicated Confectionery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Medicated Confectionery Market

A detailed market share analysis in the Medicated Confectionery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Medicated Confectionery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Medicated Confectionery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Medicated Confectionery Market, highlighting leading vendors and their innovative profiles. These include A.L.Simpkin & Co. Ltd., Enorama Pharma AB, Tereos S.A., Mondelez International, Inc., Reckitt Benckiser Group PLC, Baker Perkins Limited by Schenck Process Group, Nestle S.A. BY Ferrero International S.A., Prince Group, Lofthouse of Fleetwood Ltd., Skyepharma Production S.A.S., Syntegon Technology GmbH, Lozy's pharmaceuticals, S.L., Ernest Jackson Ltd., GelStat Corporation, Hamac Food Industries Sdn Bhd, Piedmont Candy Company, Swan Sweets Pvt. Ltd, Herbion International Inc. by Kehkashan Group, Perfetti Van Melle Group B.V., Cargill, Inc., Glanbia PLC, UHA Mikakuto Co.Ltd., Bartek Ingredients Inc., Mars Incorporated, Creasy Foods Ltd., and Lozen Pharma Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Medicated Confectionery Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Chewing Gums, Hard Boiled Candies, and Pastilles.
• Based on Labeling, market is studied across Conventional and Sugar-free.
• Based on Distribution Channel, market is studied across Convenience Stores, Online Retail, Specialist Stores, and Supermarkets & Hypermarkets.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing Demand for Fortified/Functional Confectionery Products
    • 5.1.1.2. Rising Demand for Active Ingredients in Confectionery
    • 5.1.1.3. Increasing Cases of Allergy and Hay Fevers
  • 5.1.2. Restraints
    • 5.1.2.1. Limited Adoption Rate Due to Misconception of Medicated Confectioneries
  • 5.1.3. Opportunities
    • 5.1.3.1. Innovations in Flavor and Health Ingredients
    • 5.1.3.2. Rising Investments in the Research and Development Activities
  • 5.1.4. Challenges
    • 5.1.4.1. Volatility in Raw Material Prices of Medicated Confectionery Ingredients
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Growing demand for hard-boiled candies for their prolonged release and efficacy for throat issues
  • 5.2.2. Labeling: Rising popularity of sugar-free options due to growing health consciousness and dietary requirements.
  • 5.2.3. Distribution Channel: Increasing use of online channels due to easy accessibility and convenience
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Medicated Confectionery Market, by Type

• 6.1. Introduction
• 6.2. Chewing Gums
• 6.3. Hard Boiled Candies
• 6.4. Pastilles

7. Medicated Confectionery Market, by Labeling

• 7.1. Introduction
• 7.2. Conventional
• 7.3. Sugar-free

8. Medicated Confectionery Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Convenience Stores
• 8.3. Online Retail
• 8.4. Specialist Stores
• 8.5. Supermarkets & Hypermarkets

9. Americas Medicated Confectionery Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Medicated Confectionery Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Medicated Confectionery Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Apax Funds acquire Bazooka Candy Brands
  • 12.3.2. Nestle pledges multi-billion investment into nutritionally-enhanced ranges, including confectionery

Companies Mentioned

• 1. A.L.Simpkin & Co. Ltd.
• 2. Enorama Pharma AB
• 3. Tereos S.A.
• 4. Mondelez International, Inc.
• 5. Reckitt Benckiser Group PLC
• 6. Baker Perkins Limited by Schenck Process Group
• 7. Nestle S.A. BY Ferrero International S.A.
• 8. Prince Group
• 9. Lofthouse of Fleetwood Ltd.
• 10. Skyepharma Production S.A.S.
• 11. Syntegon Technology GmbH
• 12. Lozy's pharmaceuticals, S.L.
• 13. Ernest Jackson Ltd.
• 14. GelStat Corporation
• 15. Hamac Food Industries Sdn Bhd
• 16. Piedmont Candy Company
• 17. Swan Sweets Pvt. Ltd
• 18. Herbion International Inc. by Kehkashan Group
• 19. Perfetti Van Melle Group B.V.
• 20. Cargill, Inc.
• 21. Glanbia PLC
• 22. UHA Mikakuto Co.Ltd.
• 23. Bartek Ingredients Inc.
• 24. Mars Incorporated
• 25. Creasy Foods Ltd.
• 26. Lozen Pharma Pvt. Ltd.